BDH Industries Ltd

BDH Industries Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 02 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 March 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

BDH Industries Ltd, a notable player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 2 March 2026. This revision reflects a nuanced assessment across four critical parameters: quality, valuation, financial trend, and technicals. While the company continues to demonstrate strong financial fundamentals and long-term market-beating returns, recent technical indicators and valuation metrics have prompted a more cautious stance among analysts.

BDH Industries Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 16 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 February 2026, providing investors with the latest insights into its performance and outlook.

BDH Industries Ltd has been upgraded from a Hold to a Buy rating following a comprehensive reassessment of its financial performance, valuation metrics, technical indicators, and overall quality. The upgrade reflects the company’s robust quarterly results, improved market positioning, and favourable technical signals, positioning it as a compelling investment opportunity within the Pharmaceuticals & Biotechnology sector.

BDH Industries Ltd has witnessed a notable shift in its valuation parameters, moving from an expensive to a fair pricing territory. This recalibration, reflected in key metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios, positions the pharmaceutical and biotechnology company as a more attractive proposition relative to its historical averages and peer group benchmarks.

BDH Industries Ltd., a Mumbai-based pharmaceutical manufacturer specialising in antibiotics and anti-inflammatory formulations, has posted mixed signals in its recent quarterly performance. The ₹230 crore market capitalisation company has demonstrated strong topline momentum, yet investors are scrutinising margin sustainability and valuation concerns as the stock trades at a 3.78% premium following recent sessions.

BDH Industries Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 11 September 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 February 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

BDH Industries Ltd has witnessed a notable shift in its valuation parameters, moving from an expensive to a fair valuation territory. This change, reflected in key metrics such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios, suggests a more attractive price point for investors amid a challenging market backdrop and strong long-term returns.

BDH Industries Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 11 September 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 January 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

BDH Industries Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 11 Sep 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 January 2026, providing investors with an up-to-date view of its fundamentals, returns, and market standing.

BDH Industries Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 11 September 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 December 2025, providing investors with an up-to-date view of the company’s performance and outlook.

BDH Industries, a microcap player in the Pharmaceuticals & Biotechnology sector, has undergone a revision in its market evaluation, reflecting nuanced shifts across key financial and technical parameters. This adjustment highlights evolving perspectives on the company’s quality, valuation, financial trends, and technical outlook amid a backdrop of mixed performance indicators.